Free press releases distribution network?

Agency / Source: Alto Marketing Ltd

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

New Seward U.S Offices Achieve Sales Success - Seward sees 7500th Stomacher® 400 Circulator Paddle Blender sale
New Seward U.S Offices Achieve Sales Success


PRZOOM - /newswire/ - Southampton, Hampshire, United Kingdom, 2010/01/26 - Seward sees 7500th Stomacher® 400 Circulator Paddle Blender sale.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Seward Limited, manufacturer and developer of the world leading, patented Stomacher® Paddle Blender range for over 40 years, has recently achieved its 7500th global sale of its Stomacher® 400 Circulator. This success can be attributed to its growing US-based sales and technical support office, opened in Long Island, New York in September 2008, backed up by Seward’s global Headquarters in the UK, where all Stomacher blender systems are manufactured. Seward Laboratory Systems, Inc. ( works closely with North American customers to deliver quality products and guarantee stock availability for food safety and life science sample preparation prior to microbiological analyses or PCR techniques.

Over 8 million food samples a day are now reproducibly homogenised using Stomacher® 400 paddle blender units and associated Stomacher® bags worldwide. Sample preparation is a critical step in all microbiological analyses and Stomacher paddle blenders guarantee reliable and consistent homogenising performance through industrial strength, power and build quality. Such is their quality, all Stomacher Lab Blenders hold a 3 year no quibble warranty.

The global success of the Stomacher® range of paddle blenders and bags is also demonstrated by the fact that Stomacher is the most highly referenced brand name in food safety and life science sample preparation. “We are extremely proud of the long history and excellent reputation of our Stomacher trademarked products, some of which are still in reliable routine use after 25 years,” said Stuart Ray, Technical Director, Seward Ltd. “The 7500th global sale of our Stomacher 400 Circulator system further highlights the world leading status of our Stomacher brand.”

Due to its unique patented paddle design the Stomacher® 400 Circulator blender enhances microorganism recovery over square paddle designed laboratory blenders. The stirring and extrusion forces applied to the sample by its patented design drive more organisms into suspension for analysis, making the Stomacher Circulator the gold standard in laboratory blenders. Used in conjunction with the Stomacher® Bag range, which fulfils all blending, straining and storage applications, the Circulator enables easy and effective processing of multiple samples without risk of cross contamination.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: Alto Marketing Ltd


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

New Seward U.S Offices Achieve Sales Success

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Contact: Leigh Dilley 
+44 1489 557672 sarahp[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Alto Marketing Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Press Releases From Alto Marketing Ltd / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy
Greenphire Continues Commitment to Clinical Research Site Sustainability and Innovation at Global Site Solutions Summit
Frost & Sullivan Highlights argenx for Enhancing the Therapeutic Qualities of Human Antibodies with its Proprietary Antibody Discovery Platform, SIMPL
FDA Grants Breakthrough Therapy Designation for Genentech’s Actemra® (Tocilizumab) in Giant Cell Arteritis, a Form of Vasculitis

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...


Visit  NAKIVO, Inc.


Visit  Demyk Lightmod Products, Inc.

  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today